Salivary Gland Adenocarcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Salivary Gland Adenocarcinoma

subtype

Identifier: CI-CAN-00006614
Entity page: /cancer/salivary-gland-adenocarcinoma ↗
Edges: 14

Neighbours: 4 drugs10 trials
Drawn: 14 of 14 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Salivary Gland Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Trastuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Salivary Gland Adenocarcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Bicalutamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants

Salivary Gland Adenocarcinoma studied in …STUDIED_INderived10 of 10
→ studied in	NCT07072676NA · enrolling by invitation The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period. · condition mapped ALIAS · 10 trials mapped (2 active)	—	—	Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05513365Phase 2 · recruiting Phase II Dutasteride in Combination With CAB vs CAB in SDC · condition mapped ONTOLOGY_EXACT · 10 trials mapped (2 active)	—	—	Salivary Duct Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04249947Phase 1 · terminated P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) · condition mapped ONTOLOGY_EXACT · 10 trials mapped (2 active)	—	—	Salivary Duct Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04291300Phase 2 · completed Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients · condition mapped ONTOLOGY_EXACT · 10 trials mapped (2 active)	—	—	Salivary Duct Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04214353NA · unknown PSMA-PET Imaging Before and After ADT in Advanced SDC Patients · condition mapped ONTOLOGY_EXACT · 10 trials mapped (2 active)	—	—	Salivary Duct Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03614364Phase 2 · unknown Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma · condition mapped ONTOLOGY_EXACT · 10 trials mapped (2 active)	—	—	Salivary Duct Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03319641NA · completed PSMA-PET Imaging for Advanced ACC/SDC · condition mapped ONTOLOGY_EXACT · 10 trials mapped (2 active)	—	—	Salivary Duct Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00095563Phase 2 · completed Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers · condition mapped CURATED_BROADER · 10 trials mapped (2 active)	—	—	Salivary Gland Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00126607Phase 2 · terminated Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer · condition mapped CURATED_BROADER · 10 trials mapped (2 active)	—	—	Salivary Gland Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00028496Phase 1 · completed Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer · condition mapped CURATED_BROADER · 10 trials mapped (2 active)	—	—	Salivary Gland Adenocarcinoma	1	Observed	clinicaltrials	graph →